Additional Study Information: The primary objective of the EOMI is to acquire tissue and blood, and other biospecimens for research purposes from tests performed for clinical care or for research indications on other research protocols to accelerate our understanding of the molecular basis of early-onset cancers occurring in racial and/or ethnic minority populations through the application of genome analysis technologies, including large-scale genome sequencing and clinical data analysis. Cancers may include breast cancer, colon and rectal cancer, kidney cancer, liver cancer, multiple myeloma, and prostate cancer.